Horizon Therapeutics PLC (NASDAQ:HZNP)

27.50
Delayed Data
As of 4:00pm ET
 +0.50 / +1.85%
Today’s Change
16.56
Today|||52-Week Range
29.44
+40.74%
Year-to-Date

Today’s Trading

Previous close27.00
Today’s open27.17
Day’s range26.94 - 27.62
Volume972,809
Average volume (3 months)1,830,760
Market cap$5.0B
Data as of 4:00pm ET, 08/19/2019

Growth & Valuation

Earnings growth (last year)+82.28%
Earnings growth (this year)-0.55%
Earnings growth (next 5 years)+17.60%
Revenue growth (last year)+14.33%
P/E ratio70.5
Price/Sales2.69
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.96+1.04%
GWPHGW Pharmaceuticals P...-0.02-0.01%
GRFSGrifols SA+0.11+0.50%
ALLKAllakos Inc+0.40+0.45%
Data as of 4:00pm ET, 08/19/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)$0.49
Annual revenue (last year)$1.2B
Annual profit (last year)-$74.2M
Net profit margin-6.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Timothy P. Walbert
Senior VP-Business Operations &
Government Affairs
Robert W. Metz
Corporate headquarters
Dublin, Dublin

Forecasts